Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis (Q28294512)

1

0 references

Hinke Multhaupt

2

0 references

En Chan

3

0 references

Roland M Schaefer

5

0 references

John R Couchman

Journal of Histochemistry and Cytochemistry

6

0 references

language of work or name

English

0 references

publication date

December 2004

0 references

published in

0 references

volume

52

0 references

issue

12

0 references

page(s)

1575-90

0 references

cites work

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Form and function: the laminin family of heterotrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Basement membrane and interstitial proteoglycans produced by MDCK cells correspond to those expressed in the kidney cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

The N-terminal globular domain of the laminin alpha1 chain binds to alpha1beta1 and alpha2beta1 integrins and to the heparan sulfate-containing domains of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Myoepithelial and basement membrane antigens in benign and malignant human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Isolation of a heparan sulfate-containing proteoglycan from basement membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Structural and genetic analysis of laminin-nidogen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

21 January 2018

1 reference

https://api.crossref.org/works/10.1369%2FJHC.4A6353.2004